SCHEMBL9360907

SCHEMBL9360907

CCCCCCCCCOc1ccc(C(=O)Nc2cc(C(=O)NCCCOC)ccc2OC)cc1

nearest known ligand 0.67

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ACAT1 P24752 1/20 0.67
HDAC1 Q13547 2/20 0.59
HDAC8 Q9BY41 2/20 0.59
HDAC6 Q9UBN7 2/20 0.59
SMPD1 P17405 5/20 0.58
MAPT P10636 1/20 0.56
TSHR P16473 1/20 0.56
MAPK1 P28482 1/20 0.56
PLK1 P53350 4/20 0.53
ALDH1A1 P00352 1/20 0.51
TP53 P04637 1/20 0.51
GAA P10253 1/20 0.51
CNR2 P34972 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9361457 1.00 ACAT1 (0.67) ACAT1HDAC1HDAC8HDAC6SMPD1
SCHEMBL9362439 0.96 ACAT1 (0.73) ACAT1HDAC1HDAC8HDAC6SMPD1
SCHEMBL9361404 0.96 ACAT1 (0.70) ACAT1HDAC1HDAC8HDAC6SMPD1
SCHEMBL9365181 0.96 ACAT1 (0.73) ACAT1HDAC1HDAC8HDAC6SMPD1
SCHEMBL9362298 0.96 ACAT1 (0.73) ACAT1HDAC1HDAC8HDAC6SMPD1
SCHEMBL9365091 0.96 ACAT1 (0.70) ACAT1HDAC1HDAC8HDAC6SMPD1
SCHEMBL9361811 0.95 ACAT1 (0.66) ACAT1HDAC1HDAC8HDAC6SMPD1
SCHEMBL9362330 0.95 ACAT1 (0.66) ACAT1HDAC1HDAC8HDAC6SMPD1
SCHEMBL9365138 0.95 ACAT1 (0.66) ACAT1HDAC1HDAC8HDAC6SMPD1
SCHEMBL9361174 0.95 ACAT1 (0.71) ACAT1HDAC1HDAC8HDAC6SMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0424194-B1 Benzanilide derivatives and their use as anti-atherosclerotic agents RHONE POULENC SANTE (FR) 1994-08-31 EP disclosed
US-5159114-A Anticholesterol agents RHONE-POULENC SANTE (FR) 1992-10-27 US disclosed
EP-0424194-A2 Benzanilide derivatives and their use as anti-atherosclerotic agents RHONE-POULENC SANTE (FR) 1991-04-24 EP disclosed